« neurologisch | neuro Supplementum 02|2017

Paraneoplastic neurological syndromes

2. Mai 2017
Focus: 14. Jahrestagung der Österreichischen Gesellschaft für Neurologie

Paraneoplastic Neurological Syndromes (PNS) can be defined as remote effects of cancer that are not elicited by the tumor and its metastasis, or by infection such as ischemia or metabolic disruptions. They are caused by autoimmune processes triggered by the cancer and directed against antigens common to both the cancer and the nervous system: onconeural antigens. PNS are rare, affecting less than 1/10,000 cancer patients. Only Lambert-Eaton myasthenic syndrome is relatively frequent, occurring in approximately 1% of patients with small-cell lung cancer. PNS are usually severely disabling.

Melden Sie sich bitte kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

AutorIn: Prof. Dr. Bruno Giometto

Clinica Neurologica, University of Padova

Ursprünglich erschienen:
neuro Supplementum 02|2017
Herausgeber: Österreichische Gesellschaft für Neurologie, Prim. Univ.-Doz. Dr. Elisabeth Fertl, Präsidentin der ÖGN
Publikationsdatum: 2017-05-02
Zur Ausgabe »
« neurologisch | neuro Supplementum 02|2017